MX2008001614A - 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. - Google Patents
7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.Info
- Publication number
- MX2008001614A MX2008001614A MX2008001614A MX2008001614A MX2008001614A MX 2008001614 A MX2008001614 A MX 2008001614A MX 2008001614 A MX2008001614 A MX 2008001614A MX 2008001614 A MX2008001614 A MX 2008001614A MX 2008001614 A MX2008001614 A MX 2008001614A
- Authority
- MX
- Mexico
- Prior art keywords
- indazoles
- compositions containing
- containing same
- production method
- substituted aza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La invencion se refiere a nuevos 7-aza-indazoles especificos que tienen la formula (I), los cuales modulan la actividad de proteinas, particularmente quinasas, composiciones que contienen los mismos y el uso de los mismos como un medicamento, en particular como agentes anticancerigenos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0508316A FR2889526B1 (fr) | 2005-08-04 | 2005-08-04 | 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
PCT/FR2006/001861 WO2007017577A1 (fr) | 2005-08-04 | 2006-08-01 | 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008001614A true MX2008001614A (es) | 2008-04-04 |
Family
ID=36177926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008001614A MX2008001614A (es) | 2005-08-04 | 2006-08-01 | 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. |
Country Status (30)
Country | Link |
---|---|
US (1) | US8058290B2 (es) |
EP (1) | EP1912988B1 (es) |
JP (1) | JP5128475B2 (es) |
KR (1) | KR101263970B1 (es) |
CN (2) | CN102093353B (es) |
AR (1) | AR057719A1 (es) |
AU (1) | AU2006277855B2 (es) |
BR (1) | BRPI0614304A2 (es) |
CA (1) | CA2617293C (es) |
CR (1) | CR9678A (es) |
DO (1) | DOP2006000179A (es) |
EA (1) | EA019302B1 (es) |
EC (1) | ECSP088152A (es) |
FR (1) | FR2889526B1 (es) |
HK (1) | HK1125928A1 (es) |
HN (1) | HN2008000188A (es) |
IL (1) | IL188792A0 (es) |
MA (1) | MA29652B1 (es) |
MX (1) | MX2008001614A (es) |
MY (1) | MY147488A (es) |
NI (1) | NI200800020A (es) |
NO (1) | NO20081013L (es) |
NZ (1) | NZ565396A (es) |
PE (1) | PE20070240A1 (es) |
TN (1) | TNSN08024A1 (es) |
TW (1) | TWI378930B (es) |
UA (1) | UA94417C2 (es) |
UY (1) | UY29727A1 (es) |
WO (1) | WO2007017577A1 (es) |
ZA (1) | ZA200800965B (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20061119A1 (es) * | 2005-01-19 | 2006-11-27 | Aventis Pharma Sa | PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie |
AU2007224020A1 (en) | 2006-03-07 | 2007-09-13 | Array Biopharma Inc. | Heterobicyclic pyrazole compounds and methods of use |
US8931114B2 (en) | 2008-09-22 | 2015-01-13 | The United States Of America, As Represented By The Secretary Of The Navy | Elastomeric composites with tether-containing, conducting polymers for nanoscale diffusion control |
US8120893B2 (en) * | 2008-09-22 | 2012-02-21 | The United States Of America As Represented By The Secretary Of The Navy | Tether-containing conducting polymers |
TW201103943A (en) * | 2009-04-27 | 2011-02-01 | Shionogi & Co | Urea derivative having pi3k inhibitory activity |
US8846673B2 (en) | 2009-08-11 | 2014-09-30 | Bristol-Myers Squibb Company | Azaindazoles as kinase inhibitors and use thereof |
MX2012002317A (es) | 2009-08-24 | 2012-06-25 | Ascepion Pharmaceuticals Inc | Compuestos de urea que contienen heteroarilo 5,6-biciclicos como inhibidores de cinasa. |
US20120232062A1 (en) * | 2009-10-20 | 2012-09-13 | Eiger Biopharmaceuticals, Inc. | Azaindazoles to treat flaviviridae virus infection |
FR2954943B1 (fr) * | 2010-01-07 | 2013-03-01 | Sanofi Aventis | Derives de pyridino-pyridinones arylsulfonamides, leur preparation et leur application en therapeutique |
US8637509B2 (en) * | 2010-05-07 | 2014-01-28 | Glaxosmithkline Llc | Azaindazoles |
CA2841142C (en) | 2010-06-23 | 2020-12-15 | Ryan D. Morin | Biomarkers for non-hodgkin lymphomas and uses thereof |
JP6389036B2 (ja) | 2010-09-10 | 2018-09-12 | エピザイム インコーポレイテッド | ヒトezh2の阻害剤、およびその使用方法 |
US9175331B2 (en) | 2010-09-10 | 2015-11-03 | Epizyme, Inc. | Inhibitors of human EZH2, and methods of use thereof |
JP2014511389A (ja) * | 2011-02-28 | 2014-05-15 | エピザイム インコーポレイテッド | 置換6,5−縮合二環式ヘテロアリール化合物 |
TWI598336B (zh) | 2011-04-13 | 2017-09-11 | 雅酶股份有限公司 | 經取代之苯化合物 |
JO3438B1 (ar) | 2011-04-13 | 2019-10-20 | Epizyme Inc | مركبات بنزين مستبدلة بأريل أو أريل غير متجانس |
US9073924B2 (en) | 2011-09-13 | 2015-07-07 | Glaxosmithkline Llc | Azaindazoles |
EP2760862B1 (en) * | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
FR2984325A1 (fr) * | 2011-12-14 | 2013-06-21 | Sanofi Sa | Derives de pyrazolopyridine, leur procede de preparation et leur application en therapeutique |
US10138235B2 (en) | 2011-12-14 | 2018-11-27 | Sanofi | Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof |
HUE060881T2 (hu) | 2012-04-13 | 2023-04-28 | Epizyme Inc | Sóforma az EZH2 gátláshoz |
WO2013167403A1 (en) | 2012-05-09 | 2013-11-14 | Sanofi | Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors |
EP2906537B1 (en) | 2012-10-15 | 2020-03-11 | Epizyme, Inc. | Substituted benzene compounds |
UA111305C2 (uk) | 2012-12-21 | 2016-04-11 | Пфайзер Інк. | Конденсовані лактами арилу та гетероарилу |
TWI629275B (zh) * | 2013-03-13 | 2018-07-11 | 賽諾菲公司 | N-(4-(氮雜吲唑-6-基)-苯基)-磺醯胺及其作為醫藥之用途 |
PL3057962T3 (pl) | 2013-10-16 | 2024-01-29 | Epizyme, Inc. | Postać soli chlorowodorku do inhibicji ezh2 |
EP3521285A1 (en) | 2014-06-17 | 2019-08-07 | Pfizer Inc | Substituted dihydroisoquinolinone compounds |
US11059817B2 (en) * | 2015-09-23 | 2021-07-13 | The Regents Of The University Of California | Potent antiviral pyrazolopyridine compounds |
CN107619388A (zh) | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
CN107840842A (zh) | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
JP7007374B2 (ja) | 2016-09-23 | 2022-01-24 | ノバルティス アーゲー | 腱及び/又は靭帯損傷に使用するためのインダゾール化合物 |
JOP20190053A1 (ar) | 2016-09-23 | 2019-03-21 | Novartis Ag | مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط |
AU2017373758B2 (en) * | 2016-12-07 | 2021-12-16 | Orimos Therapeutics Co., Ltd. | Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof |
US11548867B2 (en) | 2017-07-19 | 2023-01-10 | Idea Ya Biosciences, Inc. | Amido compounds as AhR modulators |
CN111138426B (zh) * | 2018-11-02 | 2023-03-10 | 安徽中科拓苒药物科学研究有限公司 | 吲唑类激酶抑制剂及其用途 |
CN109456280B (zh) * | 2018-12-24 | 2020-11-10 | 锦州医科大学 | 含有脲结构的4-苯基噻唑-2-胺类衍生物及其制备方法与应用 |
WO2020178316A1 (en) * | 2019-03-05 | 2020-09-10 | Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.P.A. | 5- or 7-azaindazoles as beta-lactamase inhibitors |
MX2021015996A (es) | 2019-07-11 | 2022-06-08 | Escape Bio Inc | Indazoles y azaindazoles como inhibidores de cinasa de repetición rica en leucina 2 (lrrk2). |
IL309118A (en) | 2021-06-28 | 2024-02-01 | Blueprint Medicines Corp | CDK2 inhibitors |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1302287A (es) * | 1970-07-21 | 1973-01-04 | ||
DE2538950A1 (de) * | 1975-09-02 | 1977-03-03 | Basf Ag | Verfahren zur herstellung von 2,6- dichlor-nicotinsaeuren |
DE2701610A1 (de) | 1977-01-17 | 1978-07-20 | Basf Ag | Farbstoffzubereitungen fuer cellulose und cellulosehaltiges textilmaterial und neue farbstoffe |
DD154538A1 (de) * | 1979-07-30 | 1982-03-31 | Eberhard Schroetter | Verfahren zur herstellung substituierter 2,4-und 2,6-dihalogen-pyridine |
JPH04117362A (ja) * | 1990-09-07 | 1992-04-17 | Idemitsu Kosan Co Ltd | ピリジン誘導体およびその塩ならびに該物質を有効成分とする殺虫・殺ダニ剤 |
PL354241A1 (en) * | 1999-09-17 | 2003-12-29 | Abbott Gmbh & Co.Kgabbott Gmbh & Co.Kg | Kinase inhibitors as therapeutic agents |
AU2001287654B2 (en) | 2000-08-10 | 2006-12-14 | Pfizer Italia S.R.I. | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
JP4272338B2 (ja) * | 2000-09-22 | 2009-06-03 | バイエル アクチェンゲゼルシャフト | ピリジン誘導体 |
US6977262B2 (en) * | 2001-02-02 | 2005-12-20 | Mitsubishi Pharma Corporation | Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
FR2827603B1 (fr) * | 2001-07-18 | 2003-10-17 | Oreal | Composes derives de diaminopyrazole substitues par un radical heteroaromatique et leur utilisation en teinture d'oxydation des fibres keratiniques |
EP1432706A2 (en) * | 2001-09-26 | 2004-06-30 | Bayer Pharmaceuticals Corporation | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
GB0128287D0 (en) | 2001-11-26 | 2002-01-16 | Smithkline Beecham Plc | Novel method and compounds |
WO2003068773A1 (en) * | 2002-02-12 | 2003-08-21 | Glaxo Group Limited | Pyrazolopyridine derivatives |
AU2003254051A1 (en) | 2002-07-23 | 2004-02-09 | Smithkline Beecham Corporation | Pyrazolopyrimidines as kinase inhibitors |
AU2003259749A1 (en) * | 2002-08-12 | 2004-02-25 | Sugen, Inc. | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
WO2004076450A1 (en) | 2003-02-27 | 2004-09-10 | J. Uriach Y Compañia S.A. | Pyrazolopyridine derivates |
WO2004096130A2 (en) * | 2003-04-24 | 2004-11-11 | Merck & Co., Inc. | Inhibitors of akt activity |
AU2004259012C1 (en) | 2003-07-23 | 2012-08-02 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
WO2005027095A1 (ja) | 2003-09-16 | 2005-03-24 | Matsushita Electric Industrial Co., Ltd. | 符号化装置および復号化装置 |
KR100703068B1 (ko) * | 2003-12-30 | 2007-04-05 | 에스케이케미칼주식회사 | 피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물 |
GB0402137D0 (en) * | 2004-01-30 | 2004-03-03 | Smithkline Beecham Corp | Novel compounds |
US20060074102A1 (en) | 2004-05-14 | 2006-04-06 | Kevin Cusack | Kinase inhibitors as therapeutic agents |
FR2871158A1 (fr) * | 2004-06-04 | 2005-12-09 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
US7563781B2 (en) | 2005-01-14 | 2009-07-21 | Janssen Pharmaceutica Nv | Triazolopyrimidine derivatives |
PE20061119A1 (es) | 2005-01-19 | 2006-11-27 | Aventis Pharma Sa | PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie |
BRPI0608252A2 (pt) | 2005-03-10 | 2010-04-06 | Cgi Pharmaceuticals Inc | entidades quìmicas, composições farmacêuticas compreendendo as mesmas, métodos utilizando as referidas entidades quìmicas e uso das referidas entidades quìmicas |
US7928126B2 (en) * | 2005-04-28 | 2011-04-19 | Mitsubishi Tanabe Pharma Corporation | Cyanopyridine derivative and use thereof as medicine |
CA2627089A1 (en) | 2005-11-09 | 2007-05-18 | Memory Pharmaceuticals Corporation | 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
-
2005
- 2005-08-04 FR FR0508316A patent/FR2889526B1/fr not_active Expired - Fee Related
-
2006
- 2006-08-01 UA UAA200802787A patent/UA94417C2/ru unknown
- 2006-08-01 MX MX2008001614A patent/MX2008001614A/es active IP Right Grant
- 2006-08-01 CN CN2011100326106A patent/CN102093353B/zh not_active Expired - Fee Related
- 2006-08-01 CA CA2617293A patent/CA2617293C/fr not_active Expired - Fee Related
- 2006-08-01 NZ NZ565396A patent/NZ565396A/en not_active IP Right Cessation
- 2006-08-01 EA EA200800514A patent/EA019302B1/ru not_active IP Right Cessation
- 2006-08-01 ZA ZA200800965A patent/ZA200800965B/xx unknown
- 2006-08-01 CN CN2006800323586A patent/CN101304998B/zh not_active Expired - Fee Related
- 2006-08-01 WO PCT/FR2006/001861 patent/WO2007017577A1/fr active Application Filing
- 2006-08-01 JP JP2008524545A patent/JP5128475B2/ja not_active Expired - Fee Related
- 2006-08-01 AU AU2006277855A patent/AU2006277855B2/en not_active Ceased
- 2006-08-01 EP EP06794254.0A patent/EP1912988B1/fr active Active
- 2006-08-01 BR BRPI0614304-0A patent/BRPI0614304A2/pt not_active IP Right Cessation
- 2006-08-02 DO DO2006000179A patent/DOP2006000179A/es unknown
- 2006-08-02 MY MYPI20063746A patent/MY147488A/en unknown
- 2006-08-02 PE PE2006000933A patent/PE20070240A1/es not_active Application Discontinuation
- 2006-08-03 AR ARP060103384A patent/AR057719A1/es not_active Application Discontinuation
- 2006-08-04 UY UY29727A patent/UY29727A1/es not_active Application Discontinuation
- 2006-08-04 TW TW095128577A patent/TWI378930B/zh not_active IP Right Cessation
-
2008
- 2008-01-15 IL IL188792A patent/IL188792A0/en unknown
- 2008-01-18 NI NI200800020A patent/NI200800020A/es unknown
- 2008-01-18 TN TNP2008000024A patent/TNSN08024A1/en unknown
- 2008-01-22 CR CR9678A patent/CR9678A/es unknown
- 2008-01-28 MA MA30609A patent/MA29652B1/fr unknown
- 2008-01-29 US US12/021,638 patent/US8058290B2/en active Active
- 2008-01-30 EC EC2008008152A patent/ECSP088152A/es unknown
- 2008-02-01 KR KR1020087002822A patent/KR101263970B1/ko not_active IP Right Cessation
- 2008-02-04 HN HN2008000188A patent/HN2008000188A/es unknown
- 2008-02-26 NO NO20081013A patent/NO20081013L/no not_active Application Discontinuation
-
2009
- 2009-05-07 HK HK09104212.5A patent/HK1125928A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN08024A1 (en) | 7-substituted aza-indazoles, compositions containing same, production method and use thereof | |
MX2007008790A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso. | |
TW200801003A (en) | Novel compounds | |
TW200738659A (en) | Novel compounds | |
TW200745114A (en) | Novel compounds | |
TW200800999A (en) | Novel compounds | |
TW200745084A (en) | Novel compounds | |
CY1110209T1 (el) | Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα | |
TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
MX2007003108A (es) | Compuestos imidazo-3-il-amina sustituidos y biciclicos. | |
MXPA06011327A (es) | Azaindoles utiles como inhibidores de jak y otras proteinas cinasas. | |
MX2011001679A (es) | Derivados de flavina. | |
WO2007125103A3 (en) | Benzamide glucokinase activators | |
TW200616995A (en) | Novel compounds | |
PL1891004T3 (pl) | Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych | |
TW200700064A (en) | Novel compounds | |
TW200745122A (en) | New compounds I | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
TW200635917A (en) | Novel compounds | |
TW200734306A (en) | Novel compounds, their preparation and use | |
TW200635916A (en) | Compounds | |
MY154970A (en) | Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |